Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07129031) titled 'Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock' on Aug. 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: Xijing Hospital
Condition:
Hemorrhage
Hemorrhagic Shock
Upper Gastrointestinal Bleeding (UGIB)
Intervention:
Drug: low-titer O-group whole blood
Drug: 1:1:1 component transfusion
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: September 1, 2025
Target Samp...